Usman Nazir, M.D.

Professional Background

Usman Nazir, MD Assistant Professor of Medicine Division of Pulmonary, Critical Care and Sleep Medicine University of Kansas Medical Center
Dr. Usman Nazir is an Assistant Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Kansas Medical Center. Triple board-certified by the American Board of Internal Medicine in Pulmonary Disease, Critical Care Medicine, and Sleep Medicine, Dr. Nazir brings a comprehensive, integrated approach to the care of patients with complex respiratory, critical illness, and sleep-related conditions.
In the KU Sleep Medicine Clinic, Dr. Nazir provides a full spectrum of diagnostic and therapeutic services for patients across the breadth of sleep medicine — with particular expertise in the evaluation and treatment of obstructive sleep apnea. His clinical practice encompasses:
Obstructive and central sleep apneaInsomniaRestless legs syndrome and periodic limb movement disorderNarcolepsy and other disorders of hypersomnolenceParasomnias, including sleepwalking, sleep-related eating disorder, and REM sleep behavior disorderCircadian rhythm sleep-wake disordersSleep-related neurological disordersSleep disturbances associated with underlying medical or psychiatric conditionsBeyond the sleep clinic, Dr. Nazir maintains an active pulmonary and critical care practice, with procedural expertise in advanced bronchoscopy and pleural-based interventions. He is committed to the academic mission of the University of Kansas Medical Center through teaching, mentorship, and scholarly work — including ongoing quality improvement and clinical research initiatives aimed at advancing the care of patients with sleep and respiratory disorders.

Dr. Nazir is dedicated to delivering compassionate, evidence-based care while training the next generation of pulmonary, critical care, and sleep medicine physicians.

• BA, BA in History , University of San Diego, San Diego, CA
• MD, MD, Jagiellonian University, Krakow, Poland
• Residency, Internal Medicine, The University of Kansas Medical Center, Kansas City, Kansas
• Clinical Fellowship, Pulmonary and Critical Care Medicine , The University of Kansas Medical Center, Kansas City, Kansas
• Clinical Fellowship, Sleep Medicine , The University of Kansas Medical Center, Kansas City, Kansas

• Critical Care:, American Board of Internal Medicine
• Internal Medicine, American Board of Internal Medicine
• Kansas Medical License, Kansas State Board of Healing Arts
• Pulmonary, American Board of Internal Medicine
• Sleep Medicine: , American Board of Internal Medicine

• American Academy of Sleep Medicine, Member, 2014 - Present
• American College of Chest Physicians, Member, 2012 - Present
• American Thoracic Society, Member, 2012 - Present
• American College of Physicians, Member, 2008 - Present
• American Medical Association, Member of American Medical Association , Member, 2008 - Present

---

• A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 , NHLBI, Sub-Investigator

• Nazir Usman, Dismang Nathan, Shi Xiaosong. 2022. 223: Colchicine in the Prevention of ARDS in Hospitalized COVID-19 Patients: A Retrospective Analysis. Critical Care Medicine, 50 (1), 96
• Bengtson CD, Montgomery RN, Nazir U, Satterwhite L, Kim MD, Bahr NC, Castro M, Baumlin N, Salathe M. 2021. An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19.. Frontiers in medicine, 8, 630209
• Polineni D, Jandali MB, Streiler C, Nazir U, Postigo Jasahui M, Morgan D, Smith H, Holets-Bondar L, Markiewicz M, He J, others. 2021. A Phase IIa, Double-Blinded, Randomized Placebo-Controlled Trial of MAPKAPK2 Inhibition by ATI-450 in Treatment of Moderate-Severe COVID-19 Pneumonia, A1287--A1287
• Brownback Kyle, Nazir Usman. 2014. Role of Thrombolytics in the Management of Sub-Massive Pulmonary Embolism . OA Critical Care Journal